Glycated Serum Protein (Glycated Albumin)

Glycated Serum Protein Assay is intended for the quantitative determination of glycated serum proteins in serum.

Regulatery Status: FDA 510(K), CE

Product Catalog Number Packaging Method/Format
Product Catalog No: Kit (200 Tests) Pack Size: DZ112B-K Pack Size: R1: 1 x 45 mL
R2: 1 x 14 mL
Pack Size: Colorimetric, Endpoint
Liquid Stable
Product Catalog No: Calibrator Pack Size: DZ112B-Cal Pack Size: 2 x 1 mL
Pack Size:
Product Catalog No: Control Pack Size: DZ112B-Con Pack Size: 2 x 1 mL
Pack Size:

Category:
Product Features

enzymatic assay for glycated serum protein provides improved specificity and reliability compared to conventional NBT-based methods. The assay is highly precise with a total CV ≤ 1.3%. The assay offers extensive linearity up to 1354 μmol/L. The assay has no significant interference from: ascorbic acid (5 mg /dL); bilirubin (7.5 mg/dL); bilirubin conjugated (5 mg/dL); glucose (2400 mg/dL; hemoglobin (200 mg/dL); triglycerides (2000 mg/dL); and uric acid (35 mg/dL).

Assay Principle

Glycated Serum Protein Assay uses proteinase K to digest GSP into low molecular weight glycated protein fragments (GPF), and uses Diazyme’s specific fructosaminase™, a microorganism originated amadoriase to catalyze the oxidative degradation of Amadori product GPF to yield PF or amino acids, glucosone and H2O2. The H2O2 released is measured by a colorimetric Trinder end-point reaction. The absorbance at 546-600 nm is proportional to the concentration of glycated serum proteins.

Order Enquiry

    Order Enquiry Form

    References
    1. Abidin D. et al. An Improved Enzymatic Assay for Glycated Serum Protein. Anal. Methods 2013; 5: 2461-2469
    Enquiry